Abstract
Background Serum sickness-like reactions are typically characterized by fever, arthralgia, rash, and other systemic symptoms within two weeks of antigen exposure. The most common inciting agents are non-protein drugs, most notably cefaclor. This report describes a 3-year old boy who developed a serum sickness-like reaction after receiving a course of meropenem. Materials and methods Laboratory investigations supporting a diagnosis of serum sickness-like reaction were performed. Results A 3 year old with a history of prematurity was treated with intravenous meropenem and vancomycin for a ventriculoperitoneal shunt infection and brain abscess. He developed fever, bilateral knee swelling and an erythematous maculopapular rash to his trunk and extremities on day 14 of meropenem and day 27 of vancomycin. During this time, he had elevated creatinine and C reactive protein, as well as eosinophilia and hematuria. Septic workup was negative, as were tests for autoimmunity. He also developed transient coagulopathy and pancytopenia, felt to be adverse effects of the antibiotics. He was eventually treated with 3 days of intravenous methylprednisolone, and his symptoms improved soon after. The total duration of serum sickness-like symptoms was about 2 weeks. Conclusions
Highlights
Serum sickness-like reaction associated with meropenem in a 3-year old child
Serum sickness-like reactions are typically characterized by fever, arthralgia, rash, and other systemic symptoms within two weeks of antigen exposure
Materials and methods Laboratory investigations supporting a diagnosis of serum sickness-like reaction were performed
Summary
Serum sickness-like reactions are typically characterized by fever, arthralgia, rash, and other systemic symptoms within two weeks of antigen exposure. Serum sickness-like reaction associated with meropenem in a 3-year old child From Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2010 Victoria, Canada. Background Serum sickness-like reactions are typically characterized by fever, arthralgia, rash, and other systemic symptoms within two weeks of antigen exposure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.